STK11IP (serine/threonine kinase 11 interacting protein) functions as a regulatory protein that controls the subcellular localization and activity of the tumor suppressor STK11/LKB1 1. The protein plays important roles in multiple cellular processes including immune regulation, cardiac function, and cancer biology. In immune contexts, STK11IP deficiency aggravates M1 macrophage activation in response to inflammatory stimuli, suggesting a role in modulating immune responses 2. The protein also contributes to pathological cardiac hypertrophy by activating Akt signaling through direct targeting and inhibition of PTEN phosphatase activity 3. In cancer biology, STK11IP expression is elevated in specific lung adenocarcinoma subtypes, particularly those with ERBB2 exon 20 mutations, and forms part of clinically relevant mutational pathways such as CYLC2-STK11-STK11IP combinations 45. The gene is also associated with circulating cell-free DNA mutations in chemically-induced lung cancer models, suggesting potential utility as a biomarker 6. Additionally, STK11IP shows specific genomic binding patterns in human spermatozoa, indicating possible roles in male fertility and epigenetic inheritance 7. These diverse functions highlight STK11IP's importance in cellular signaling, disease pathogenesis, and potential therapeutic targeting.